[FORM 8-K CURRENT REPORT August 28, 2009 China Pharma Holdings, Inc ------------------------------ Delaware (State or other jurisdiction of incorporation) 000-29532 73-1564807 (IRS Employer Identification Number)]
[Explanatory Note Company Common Stock Exchange Act This Registration Statement on Form 8-A is being filed by China Pharma Holdings, Inc., a Delaware corporation (the “ Item 1. Description of the Company’s Securities to be Registered Commission 1]
[Explanatory Note Company Common Stock Exchange Act This Registration Statement on Form 8-A is being filed by China Pharma Holdings, Inc., a Delaware corporation (the “ Item 1. Description of the Company’s Securities to be Registered Commission 1]
[Sinovac Announces Supply Agreement with Boryung Pharmaceutical Company Limited in South Korea Clarifies Details of Agreement with Boryung BEIJING, Sept. 2 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NYSE Amex: SVA), a leading provider of biopharmaceutical products in China, announced today that it has signed an agreement with Boryung Pharmaceutical Company Limited, a Korean manufacturer of pharmaceuticals, to collaborate on marketing efforts] [FORM 6-K __________ __________ SINOVAC BIOTECH LTD. 39 Shangdi Xi Road Haidian District Beijing 100085, People’s Republic of China X Form 20-F X Yes _______ No N/A 82- SINOVAC BIOTECH LTD. Form 6-K TABLE OF CONTENTS Page 3 4]
[Sinovac Announces Supply Agreement with Boryung Pharmaceutical Company Limited in South Korea Clarifies Details of Agreement with Boryung BEIJING, Sept. 2 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NYSE Amex: SVA), a leading provider of biopharmaceutical products in China, announced today that it has signed an agreement with Boryung Pharmaceutical Company Limited, a Korean manufacturer of pharmaceuticals, to collaborate on marketing efforts] [FORM 6-K __________ __________ SINOVAC BIOTECH LTD. 39 Shangdi Xi Road Haidian District Beijing 100085, People’s Republic of China X Form 20-F X Yes _______ No N/A 82- SINOVAC BIOTECH LTD. Form 6-K TABLE OF CONTENTS Page 3 4]
[THE9 LIMITED Jun Zhu Chairman and Chief Executive Officer The9 Limited Selects Deloitte as its Independent Registered Public Accounting Firm Shanghai, China September 28, 2009. The9 Limited (NASDAQ: NCTY) (The9 or the Company), an online game operator and developer in China, today announced that the Audit Committee of its Board of Directors has engaged the services of Deloitte Touche]
[Sinovac's H1N1 Vaccine Passes Experts Evaluation Organized by SFDA BEIJING, Aug. 31 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NYSE Amex: SVA), a leading provider of biopharmaceutical products in China, announced today that Sinovac's H1N1 vaccine has passed the experts evaluation organized by State Food and Drug Administration (SFDA). The vaccine is expected to obtain the production license within this week. On] [FORM 6-K __________ __________ SINOVAC BIOTECH LTD. 39 Shangdi Xi Road Haidian District Beijing 100085, People’s Republic of China X Form 20-F X Yes _______ No N/A 82- SINOVAC BIOTECH LTD. Form 6-K TABLE OF CONTENTS Page 3 4]
[THE9 LIMITED Jun Zhu Chairman and Chief Executive Officer The9 Limited Selects Deloitte as its Independent Registered Public Accounting Firm Shanghai, China September 28, 2009. The9 Limited (NASDAQ: NCTY) (The9 or the Company), an online game operator and developer in China, today announced that the Audit Committee of its Board of Directors has engaged the services of Deloitte Touche]
